Skip to main content

Advertisement

Log in

Methadone-induced Torsade de pointes after stopping lopinavir–ritonavir

  • Brief Report
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Viskin S, Justo D, Halkin A, Zeltser D (2003) Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis 45:415–427

    PubMed  CAS  Google Scholar 

  2. Abriel H, Schlapfer J, Keller DI, Gavillet B, Buclin T, Biollaz J, Stoller R, Kappenberger L (2004) Molecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy. Swiss Med Wkly 134:685–694

    PubMed  CAS  Google Scholar 

  3. Tartini R, Kappenberger L, Steinbrunn W, Meyer UA (1982) Dangerous interaction between amiodarone and quinidine. Lancet 1:1327–1329

    Article  PubMed  CAS  Google Scholar 

  4. Zeltser D, Justo D, Halkin A, Prokhorov V, Heller K, Viskin S (2003) Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) 82:282–290

    Article  Google Scholar 

  5. Katchman AN, McGroary KA, Kilborn MJ, Kornick CA, Manfredi PL, Woosley RL, Ebert SN (2002) Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J Pharmacol Exp Ther 303:688–694

    Article  PubMed  CAS  Google Scholar 

  6. Wang JS, DeVane CL (2003) Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro. Drug Metab Dispos 31:742–747

    Article  PubMed  CAS  Google Scholar 

  7. Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS (2002) Torsade de pointes associated with very-high-dose methadone. Ann Intern Med 137:501–504

    PubMed  CAS  Google Scholar 

  8. Sticherling C, Schaer BA, Ammann P, Maeder M, Osswald S (2005) Methadone-induced Torsade de pointes tachycardias. Swiss Med Wkly 135:282–285

    PubMed  CAS  Google Scholar 

  9. Gil M, Sala M, Anguera I, Chapinal O, Cervantes M, Guma JR, Segura F (2003) QT prolongation and Torsades de pointes in patients infected with human immunodeficiency virus and treated with methadone. Am J Cardiol 92:995–997

    Article  PubMed  CAS  Google Scholar 

  10. Clarke S, Mulcahy F, Bergin C, Reynolds H, Boyle N, Barry M, Back DJ (2002) Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir–ritonavir. Clin Infect Dis 34:1143–1145

    Article  PubMed  CAS  Google Scholar 

  11. McCance-Katz EF, Rainey PM, Friedland G, Jatlow P (2003) The protease inhibitor lopinavir–ritonavir may produce opiate withdrawal in methadone-maintained patients. Clin Infect Dis 37:476–482

    Article  PubMed  CAS  Google Scholar 

  12. Lea AP, Faulds D (1996) Ritonavir. Drugs 52:541–546, discussion 547–548

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. J. Mueller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lüthi, B., Huttner, A., Speck, R.F. et al. Methadone-induced Torsade de pointes after stopping lopinavir–ritonavir. Eur J Clin Microbiol Infect Dis 26, 367–369 (2007). https://doi.org/10.1007/s10096-007-0293-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-007-0293-5

Keywords

Navigation